top of page
skin cancer champions logo_nobg_edited.png

Dermatology Surveillance Guidelines for Nonmelanoma Skin Cancers

Authored by

Pavane Gorrepati, MD

Nonmelanoma skin cancers (basal cell carcinoma and squamous cell carcinoma) are the most common skin cancers in the U.S. For people with a history of these cancers, regular dermatology follow-up is recommended to detect recurrences or new cancers early. The NCCN advises complete skin exams every 6–12 months for the first 5 years after a basal cell carcinoma diagnosis, then annually for life. For squamous cell carcinoma, follow-up should be every 3–12 months in the first 2 years, then once or twice yearly for the next 3 years, and annually after 5 years. Patients with higher risk features—such as lymph node involvement, perineural invasion, or immunosuppression—may need more frequent exams and imaging. Because the 5-year risk of another skin cancer is at least 41%, and rises to 82% with multiple prior cancers, ongoing surveillance is critical.



Click below to download this resource.

bottom of page